OctavaPink for Women With Dense Breast After Negative Mammography
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Edith Perez, Prof.
Mayo Clinic, Jacksonville Florida USA
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Shaarey Tzedek
Jerusalem, Israel
Strano, Prof. - Shiba
Ramat Gan, Israel
Sklair, Dr. - Kaplan Medical Center
Rehovot, Israel
Tanir Allweis, Dr. - Sourasky Medical Center
Tel Aviv, Israel
Orit Golan, Dr.
- Fondazione Carlo Ferri
Rome, Italy
Iacobelli, Dr.
- Detroit Clinical Research Center
Detroit, Michigan, United States
- Md Anderson Cancer Center
Houston, Texas, United States
Bevers, Prof.
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2014
- Primary completion
- 31 Aug 2015
- Completion
- 31 Aug 2017
- Last update posted
- 19 Aug 2014
- Registered enrollment
- 1,750
- Registry id
- NCT02209389
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.